A Note on Peptides by Shantanu Out of Singapore An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA's Overreach on Compounded Peptides How did BPC 157 become the wellness industry's star peptide? Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to FDA Peptide Reclassification 2026: What It Means for Providers